“Clinical And Genomic Analysis Of Metastatic Disease Progression In A Background Of Biochemical Recurrence”. In 2012 Astro - American Society For Radiation Oncology. 2012 Astro - American Society For Radiation Oncology. Boston, MA. https://www.astro.org/Meetings-and-Events/2012-Annual-Meeting/Index.aspx.
. 2012. “Comparison Of Clinical And Genomic Models For Prediction Of Rapid Metastatic Disease After Radical Prostatectomy”. In American Urological Association Annual Meeting. American Urological Association Annual Meeting. San Diego, CA. http://www.aua2013.org/.
. 2013. “Development And Validation Of A Novel Genomic Classifier For Predicting Metastatic Prostate Cancer In Patients Undergoing Radical Prostatectomy”. In Society Of Urologic Oncology. Society Of Urologic Oncology. Bethesda, MD. http://suonet.org/news/SUO%20precon%20news%202012.pdf.
. 2012. . 2014.
“Efficacy Of Post-Operative Radiation In A Prostatectomy Cohort Adjusted For Clinical And Genomic Risk.”. Prostate Cancer Prostatic Dis 19 (3). Prostate Cancer Prostatic Dis: 277-82. doi:10.1038/pcan.2016.15.
. 2016. “A Genomic Classifier Predicting Metastatic Disease Progression In Men With Biochemical Recurrence After Prostatectomy”. Prostate Cancer Prostatic Dis 17. Prostate Cancer Prostatic Dis: 64-69. http://www.ncbi.nlm.nih.gov/pubmed/24145624.
. 2014. “A Genomic Classifier Predicting Metastatic Disease Progression In Men With Biochemical Recurrence After Prostatectomy.”. Prostate Cancer Prostatic Dis 17 (1). Prostate Cancer Prostatic Dis: 64-9. doi:10.1038/pcan.2013.49.
. 2014. . 2013.
“Impact Of A Genomic Classifier Of Metastatic Risk On Treatment Recommendations Post-Radical Prostatectomy: Report From The Decide Study Group”. In American Society Of Clinical Oncology Annual Meeting. American Society Of Clinical Oncology Annual Meeting. Chicago IL. http://meetinglibrary.asco.org/content/117341-132.
. 2013. “Performance Of A Genomic Classifier That Predicts Metastatic Disease Progression In Men With Biochemical Recurrence Post Radical Prostatectomy”. In American Urological Association Annual Meeting. American Urological Association Annual Meeting. San Diego, CA. http://www.aua2013.org/.
. 2013. . 2013.
“Validation Of A Genomic Classifier That Predicts Metastatic Disease Rogression In Men With Biochemical Recurrence Post Radical Prostatectomy”. In American Society Of Clinical Oncology (Asco) 2013. American Society Of Clinical Oncology (Asco) 2013. Chicago, IL. http://meetinglibrary.asco.org/content/114184-132.
. 2013. “Validation Of A Genomic Classifier That Predicts Metastatic Disease Progression In Men With Biochemical Recurrence Post Radical Prostatectomy”. In American Society Of Clinical Oncology, Genitourinary Cancers Symposium. American Society Of Clinical Oncology, Genitourinary Cancers Symposium. Orlando, FL. http://gucasym.org/past-symposia.
. 2013. “Validation Of A Genomic Classifier That Predicts Metastatic Disease Progression In Men With High-Risk Pathologic Features Postprostatectomy”. In American Society Of Clinical Oncology, Genitourinary Cancers Symposium. American Society Of Clinical Oncology, Genitourinary Cancers Symposium. Orlando, FL. http://f1000.com/posters/browse?conferenceId=253893713.
. 2013. “Validation Of A Genomic Classifier That Predicts Metastatic Disease Progression In Men With High Risk Pathological Features Post-Prostatectomy”. In American Urological Association Annual Meeting. American Urological Association Annual Meeting. San Diego, CA. http://www.aua2013.org/.
. 2013.